5-fluorouracil plus bevacizumab plus anakinra for patients with metastatic colorectal cancer refractory to standard therapies (IRAFU): An investigator-initiated, open-label, single-arm, multicentre, phase 2 study.

Affiliation auteurs!!!! Error affiliation !!!!
Titre5-fluorouracil plus bevacizumab plus anakinra for patients with metastatic colorectal cancer refractory to standard therapies (IRAFU): An investigator-initiated, open-label, single-arm, multicentre, phase 2 study.
Type de publicationJournal Article
Year of Publication2018
AuteursIsambert N, Hervieu A, Hennequin A, Borg C, Rebe C, Derangere V, Richard C, Blanc J, Bertaut A, Ghiringhelli F
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume36
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2018.36.15_suppl.e15540